A fixed-ratio combination of repair and cosmetic sequences — useful for screening, no use at all for attribution.
- Contains
- a fixed-ratio combination of GHK-Cu with the tissue repair peptides BPC-157 and TB-500 (component amounts stated on the batch Certificate of Analysis)
- Strength
- 70mg total per vial
- Appearance
- lyophilised powder (combined cake)
- Reference
- GLOW70
- Purity
- ≥99% by HPLC, identity confirmed by mass spectrometry
- Released against
- the Certificate of Analysis for its own batch
About GLOW
GLOW combines repair and cosmetic peptides in a fixed ratio in a single vial, typically pairing the tissue-repair sequences with the copper tripeptide studied for dermal matrix signalling. The components are drawn from mechanisms covered individually elsewhere in the catalogue.
It is worth being explicit about what a combination preparation is. It is a screening instrument. It tells you whether a multi-component intervention moves an endpoint; it cannot tell you which component moved it, in what proportion, or whether two of them interacted.
What the research covers
Suited to exploratory dermal work where the question is whether a combined intervention produces an effect worth investigating properly. Not suited to mechanistic work, where the single sequences — BPC-157, TB-500, GHK-Cu — are the right starting point.
The fixed ratio is also a constraint rather than a neutral detail: where the ratio is the variable of interest, this preparation cannot vary it. The skin and cosmetic research peptides hub covers the three mechanisms in this group.
Handling GLOW
Supplied lyophilised as a combined cake. A multi-component preparation inherits the strictest requirement among its components rather than an average, and here that means the copper complex: light-sensitive and pH-dependent.
Protect from light, store cold and sealed, reconstitute gently and prepare fresh. The components also differ in adsorption behaviour, so the shortest sequence governs how much material is lost to container surfaces.
Solvent options are under reconstitution supplies.
Common questions about GLOW
What is in GLOW?
A fixed-ratio combination of the copper tripeptide GHK-Cu with the tissue repair peptides BPC-157 and TB-500. Amounts for each batch are on its Certificate of Analysis.
How does GLOW differ from KLOW?
KLOW adds KPV, an anti-inflammatory tripeptide, to the same combination.
Can an effect be attributed to one component?
No. A fixed combination cannot show which component produced an effect or whether components interacted. That requires the single compounds run alongside it.
Can the ratio between components be changed?
No. The ratio is fixed in the vial, so studies where the ratio is the variable of interest need the single compounds.
